Related by context. All words. (Click for frequent words.) 66 Cytotoxic 66 antiandrogen 65 benign prostatic hypertrophy BPH 65 beta interferons 64 candidemia 64 Patients Treated With 64 flutamide 64 Tigecycline 64 TMP SMX 64 Prolongs Survival 64 invasive candidiasis 64 macrolide antibiotic 63 abacavir Ziagen 63 Adefovir 63 Orally administered 63 systemic fungal infections 63 caspofungin 63 dasatinib Sprycel 63 Epidermal Growth Factor Receptor 63 hematologic abnormalities 63 Vidaza azacitidine 63 Actinic Keratosis 63 thalidomide Thalomid 63 Neoplasms 63 Fluconazole 62 ethambutol 62 Gleevec imatinib mesylate 62 colorectal liver metastases 62 benzimidazole 62 Squamous 62 hepatocellular carcinomas 62 trimethoprim sulfamethoxazole 62 ano genital warts 62 Posaconazole 62 recurrent glioblastoma multiforme 62 Papillary 62 Dasatinib 62 advanced adenomas 62 Velcade bortezomib 62 neoplasias 62 Kuvan sapropterin dihydrochloride 62 invasive aspergillosis 62 Hycamtin ® 61 Immunotherapeutic 61 Protease Inhibitors 61 cidofovir 61 Remicade infliximab 61 IOP lowering 61 Endometrial 61 micafungin 61 ergot derivatives 61 generation cephalosporins 61 indinavir 61 tyrosine kinase inhibitors TKIs 61 pyrimethamine 61 essential thrombocythemia ET 61 aripiprazole Abilify 61 GW# [003] 61 Interferon Beta 61 RhuDex ® 61 Meets Primary Endpoint 61 relapsed MM 61 ARB telmisartan 61 Itraconazole 61 Diabetic Neuropathy 61 pT2 61 Parathyroid Hormone 61 Nilotinib 61 ® lenalidomide 61 metastatic malignant 61 secondary hyperparathyroidism 61 sulindac 61 moderately emetogenic 61 RhuDex TM 61 symptomatic benign prostatic 61 Gonal f R 61 skeletal metastases 61 rilonacept 60 anthracycline containing 60 anterior uveitis 60 Enbrel Humira 60 sulfonamide 60 biliary tract cancer 60 Dacogen decitabine 60 Recombinant Human 60 Lymphocytic 60 leukemia AML 60 erlotinib Tarceva ® 60 voriconazole 60 hepatorenal syndrome 60 ergotamine 60 Advanced Renal Cell 60 Previously Treated 60 mycophenolate mofetil 60 Moxifloxacin 60 Progressive Multifocal Leukoencephalopathy 60 tigecycline 60 Cefuroxime 60 Daptomycin 60 beta lactam antibiotic 60 Contrast Agents 60 Cryopyrin Associated Periodic Syndromes 60 Erlotinib 60 IL# PE#QQR 60 Achieves Primary Endpoint 60 receptor blocker 60 itraconazole Sporanox 60 beta 1a 60 INVEGA ® 60 SinuNase TM 60 myelofibrosis polycythemia vera 60 receptor tyrosine kinase inhibitor 60 tacrolimus ointment 60 squamous cell carcinoma SCC 60 FOR FURTHER INFORMATION ABOUT 60 adalimumab Humira 60 CP CPPS 60 amphotericin B 60 stage IIIB 60 treat chronic sinusitis 60 BARACLUDE ® 60 Pemetrexed 60 completely resected 60 Irinotecan 60 combination antiretroviral therapy 60 Initiate Clinical Trial 60 Alkeran 60 oral vancomycin 60 Gleevec resistant 60 clodronate 60 KRAS mutations occur 60 Cutaneous T 60 Investigational Treatment 60 corticosteroid therapy 60 myelodysplastic myeloproliferative diseases 60 beta lactams 60 quinolone antibiotics 60 thiazides 60 FUSILEV enhances 60 Ozarelix 60 efalizumab 59 chronic hepatitis cirrhosis 59 Antifungal 59 rHuEPO 59 superficial basal cell carcinoma 59 oropharyngeal candidiasis OPC 59 MAGE A3 ASCI 59 Initiates Clinical Trial 59 nucleoside analog 59 Fludara ® 59 FluCAM arm 59 Phase 2b Clinical Trial 59 Thrombin 59 anagrelide 59 efavirenz Sustiva 59 ADPKD 59 poor metabolizers 59 renal cell carcinomas 59 nicardipine 59 hepatic metastases 59 Decitabine 59 intracranial hemorrhage ICH 59 basal cell nevus syndrome 59 Leukemias 59 epithelial tumors 59 tenofovir Viread 59 Fluorouracil 59 nondiabetic patients 59 nucleotide analogs 59 acetonide FA 59 antithrombotic agent 59 metastatic neuroendocrine tumors 59 Cytarabine 59 recurrent genital herpes 59 Antibacterials 59 Severe Sepsis 59 Noxafil 59 vapreotide acetate 59 colorectal carcinomas 59 dalteparin 59 RhuDex R 59 intravesical therapy 59 colorectal adenoma 59 herpetic keratitis 59 CAELYX 59 Cardiotoxicity 59 sorafenib Nexavar 59 cranial irradiation 59 Ganciclovir 59 oral Hycamtin 59 trimethoprim 59 Interferon alfa 59 symptomatic intracranial hemorrhage 59 seminoma 59 Genentech Rituxan 59 Shows Promise Against 59 polytherapy 59 Kepivance 59 meropenem 59 immune globulin intravenous 59 mitoxantrone plus 59 histologic subtype 59 ximelagatran 59 Atypical Hemolytic Uremic Syndrome 59 Crizotinib 59 advanced adenoma 59 Lenalidomide 59 orchitis 59 dual endothelin receptor antagonist 59 coinfected 59 Adjuvant Treatment 59 Taxanes 59 RAS mutations 59 osteosarcomas 59 Migranal 59 overactive bladder syndrome 59 hemorrhagic cystitis 59 gastrointestinal stromal tumors GIST 59 insulin glulisine 58 griseofulvin 58 Zorbtive TM 58 Bronchiectasis 58 immunosuppressives 58 metastatic gastric 58 Reminyl galantamine 58 liposomal amphotericin B 58 cutaneous T 58 dexamethasone Decadron 58 pegylated interferon alpha 58 HBeAg + 58 Allogeneic 58 antiandrogens 58 gastric adenocarcinoma 58 cinacalcet 58 pancreatic NET 58 Single Dose 58 salmeterol fluticasone 58 basiliximab 58 rifamycins 58 cytostatic 58 Xyfid TM 58 nucleoside analogs 58 cytomegalovirus retinitis 58 mitoxantrone chemotherapy 58 Sustiva efavirenz 58 Bazedoxifene 58 octreotide LAR 58 antiangiogenesis 58 acute respiratory tract infections 58 antibiotics erythromycin 58 bladder carcinoma 58 selective modulator 58 GISTs 58 refractory APL 58 fluconazole resistant 58 angiotensin converting enzyme inhibitors 58 Nexavar sorafenib 58 tiuxetan 58 pouchitis 58 K ras mutations 58 epirubicin cisplatin 58 Pafuramidine 58 alemtuzumab treated 58 pentamidine 58 Hodgkin lymphoma HL 58 interferon ribavirin 58 finasteride Proscar 58 interferon alfa 58 nonmelanoma skin cancers 58 DepoCyt 58 administered concomitantly 58 fluvastatin 58 Diabetic Macular Edema 58 clotrimazole 58 docetaxel Taxotere ® 58 imatinib Gleevec 58 invasive ductal 58 interferon gamma 1b 58 chronic eosinophilic leukemia 58 histone deacetylase HDAC inhibitor 58 Anticonvulsant 58 pentoxifylline 58 certolizumab 58 amoxicillin clavulanate 58 Infectivity 58 hypophosphatemia 58 VFEND 58 polycythemia vera essential thrombocythemia 58 Camptosar ® 58 reverse transcriptase inhibitors 58 alkylating agent 58 Rimantadine 58 castrate resistant 58 hyaluronidase enzyme 58 Tenofovir DF 58 Tarceva TM 58 unresectable HCC 58 Dendritic Cells 58 polymyxin B 58 etanercept Enbrel 58 eflornithine 58 underwent surgical resection 58 prostate carcinoma 58 Pegloticase 58 SCIg 58 thromboembolisms 58 Liprotamase 58 Asacol R 58 elevated LDH 58 HER2 overexpression 58 Prodrug 58 Roche Herceptin 58 mutated KRAS gene 58 Gets FDA Clearance 58 Abacavir 58 IFN beta 58 evaluating tivozanib 58 colorectal carcinoma 58 pimecrolimus cream 58 Bezielle 58 lamotrigine Lamictal 58 receiving INTRON 58 ertapenem 58 Completes Patient Enrollment 58 HCV Genotype 58 idraparinux 58 HGPIN 58 PHPT 58 pT3 58 CsA 57 imiquimod cream 57 Bacteremia 57 diabetes mellitus DM 57 Copegus ribavirin 57 benign prostatic hypertrophy 57 PEGylated anti 57 vinblastine 57 Detrol Detrol LA 57 Vitrasert R 57 cardiovascular calcification 57 pediatric acute lymphoblastic 57 rifamycin 57 Kinoid 57 antimicrobial prophylaxis 57 dasatinib Sprycel ® 57 PPAR gamma agonists 57 Friedreich Ataxia FRDA 57 mutated KRAS 57 PGL# 57 clinically evaluable 57 IV Busulfex 57 Amikacin 57 SPIRIVA ® 57 PD LID 57 radiosensitivity 57 Tasimelteon 57 PKC# 57 denileukin diftitox 57 Levaquin levofloxacin 57 penicillin G benzathine 57 Ribavirin causes 57 esophageal candidiasis 57 Arimidex anastrozole 57 gastric carcinoma 57 TPV r 57 headache abdominal pain 57 Zavesca R 57 FOLFIRI alone 57 rufinamide 57 dihydrochloride 57 external genital lesions 57 ritonavir boosted lopinavir 57 NYHA Class II 57 bleomycin 57 Peginterferon 57 vinca alkaloids 57 B Cell Lymphoma 57 sitagliptin metformin 57 Imiquimod 57 triglyceride concentrations 57 hematologic toxicity 57 metastatic bladder 57 briakinumab 57 Molecular Weight Heparin 57 immunomodulatory properties 57 metformin hydrochloride 57 neutropenia dehydration dyspnea 57 SUPPRELIN R LA 57 ara C 57 Gel repository corticotropin injection 57 acid phosphatase PAP 57 Mycophenolate Mofetil 57 Pegylated interferon 57 piperacillin tazobactam 57 receiving highly emetogenic 57 Submits NDA 57 SPRYCEL ® 57 hepatitis B HBV 57 S. aureus isolates 57 vinorelbine tartrate 57 leucopenia 57 relapsing remitting MS RRMS 57 Initiates Enrollment 57 Initiate Phase 57 Fixed Dose Combination 57 alefacept 57 pregabalin Lyrica 57 ALT elevation 57 Aflibercept 57 ABILIFY ® 57 antibiotics ciprofloxacin 57 canakinumab 57 primaquine 57 Anaplastic 57 CINTREDEKIN BESUDOTOX 57 Ranolazine 57 Soriatane 57 Glucocorticoid 57 polycythemia vera PV 57 rFSH 57 Systemic Sclerosis 57 Combination therapy 57 colorectal neoplasms 57 CLL SLL 57 receiving VICTRELIS 57 MCyR 57 K#N 57 trospium chloride 57 Shows Statistically Significant 57 sulfamethoxazole 57 euthyroid 57 Methylnaltrexone 57 ductal breast cancer 57 Belerofon 57 fluorouracil leucovorin 57 chronic idiopathic thrombocytopenic purpura 57 Immune Responses 57 DFMO 57 Major Depressive Disorder MDD 57 Dementia Related Psychosis 57 posterior uveitis 57 emtricitabine tenofovir 57 bovine thrombin 57 Nelfinavir 57 miconazole Lauriad ® 57 Adenoviral 57 differentiated thyroid 57 Interferon beta 1b 57 phase III isavuconazole 57 diarrhea fatigue asthenia 57 HBeAg positive 56 anthracyclines taxanes 56 Torisel 56 containing abacavir 56 BUPHENYL 56 malignant ascites 56 Trimethoprim 56 rizatriptan 56 severe malignant osteopetrosis 56 LV dysfunction 56 keratoses 56 cefazolin 56 cephalosporin antibiotics 56 albumin bound paclitaxel 56 Carbidopa 56 KRAS oncogene 56 hyaluronic acid gel 56 Chronic Lymphocytic Leukemia CLL 56 prostate adenocarcinoma 56 relapsing forms 56 atherothrombotic events 56 Peginterferon alfa 2b 56 Inhalation Aerosol 56 5-FU/LV 56 albumin excretion rate 56 indinavir Crixivan 56 humanized monoclonal 56 daunorubicin 56 ORENCIA ® 56 imatinib Gleevec ® 56 IND Application 56 Aceon 56 antiangiogenic drugs 56 metastatic renal 56 Inhalation Solution 56 Conjugate 56 porcine derived 56 achieved ACR# 56 Gastrointestinal GI 56 gonococcal 56 heparanase 56 MOVIPREP R 56 neutropenic 56 complete cytogenetic response 56 nucleotide analog 56 plasminogen activators 56 HBeAg negative 56 Vidaza R 56 BCG refractory 56 diabetic gastroparesis 56 ischemic lesions 56 systemic juvenile idiopathic 56 HDAC Inhibitor 56 Respiratory Syncytial Virus RSV 56 null responder 56 Onalta TM 56 inhibitor RG# 56 PRN FDA Approves 56 SinuNase ™ 56 cromolyn sodium 56 TNF blocker 56 soluble tumor necrosis 56 sulfasalazine 56 radezolid 56 STELARA TM 56 C1 Inhibitor 56 Oracea ® 56 Linezolid 56 AMEVIVE 56 R Saizen R 56 virologically 56 adverse reactions occurring 56 R abatacept 56 Atypical Antipsychotic 56 Files IND 56 Zenpep 56 fructose intolerance 56 cell carcinomas 56 exocrine pancreatic insufficiency EPI 56 protease inhibitor PI 56 imipenem 56 Immunomodulatory 56 pemphigus vulgaris 56 lymphoid malignancies 56 genital herpes infections 56 HCl capsules 56 AMMONUL R sodium phenylacetate 56 Actemra tocilizumab 56 Conjugated 56 NRTI resistance 56 mutated K ras 56 ARIXTRA 56 quinolone 56 ALN PCS 56 Successfully Completes Phase 56 Respiratory Virus 56 INSPIRE Trial Phase III 56 metastatic kidney 56 Proquin XR 56 clobetasol 56 antibiotic azithromycin 56 TNF antagonists 56 Hsp# Inhibitor 56 palifermin 56 Lovaza ® 56 Systemic Lupus Erythematosus SLE 56 ARIXTRA R 56 anthracycline chemotherapy 56 thetreatment 56 containing granisetron 56 endocrine therapies 56 malignant neoplasm 56 Daclizumab 56 non splenectomized 56 Azacitidine 56 YONDELIS 56 chronic thromboembolic pulmonary 56 Raltegravir 56 Cimzia TM 56 chimeric monoclonal antibody 56 inhibitory antibodies 56 GABITRIL 56 Ecallantide 56 Angiotensin 56 Amrubicin 56 Phase IIb Trial 56 PEGINTRON TM 56 timolol maleate 56 Mesalamine 56 HBeAg negative patients 56 ritonavir boosted 56 octreotide acetate 56 Deferiprone 56 Gorlin syndrome 56 Pivotal Phase III 56 opioid induced constipation OIC 56 R lenalidomide 56 Completes Enrollment 56 recurrent metastatic 56 oesophageal adenocarcinoma 56 Initiates Phase III 56 Prolastin C 56 tipranavir r 56 ADP receptor antagonist 56 enterococcal 56 mL/min/#.# m 2 56 virologic failures 56 G CSFs 55 Phase #b/#a clinical 55 oral allopurinol 55 urothelial carcinoma 55 serous ovarian cancer 55 quinolone antibiotic 55 Streptococcus pyogenes 55 p# MAP kinase inhibitor 55 ALI ARDS 55 Sutent sunitinib 55 stage IIIb IV 55 acromegalic patients 55 monophasic 55 Personalized Immunotherapy 55 interferon α 55 mRCC 55 mIU ml 55 #mg Tablets [002] 55 Randomised Study 55 Vimpat R 55 Solu Medrol 55 MGd 55 panitumumab Vectibix 55 Candida infections 55 danazol 55 Cancidas 55 norfloxacin 55 idiopathic myelofibrosis 55 URG# targets 55 Bleomycin 55 diarrhea predominant irritable 55 invasive lobular 55 Lopinavir 55 genotypic resistance 55 mucocutaneous reactions 55 rhPDGF 55 #mg ATC 55 AZT 3TC 55 amoxicillin clavulanic acid 55 Treatment Shows Promise 55 AMMONUL R 55 non resectable 55 demyelinating 55 cetuximab Erbitux R 55 undetectable viral 55 cisplatin resistant 55 p = NS 55 vaginal lesions 55 Receives Orphan Drug Designation 55 non metastatic osteosarcoma 55 bronchoalveolar lavage 55 hyperoxaluria 55 CIN2 + 55 Omiganan 55 MKC# MT 55 Valproic acid 55 beta lactamase inhibitor 55 NS#/#A protease 55 Retinoic Acid 55 hypereosinophilic syndrome 55 actinic keratosis AK 55 systemic corticosteroids 55 NNRTI resistance 55 Epivir 55 transthyretin amyloidosis 55 Phase IIb Clinical Trial 55 post herpetic neuralgia PHN 55 chronic HBV 55 recurrent colorectal cancer 55 exocrine pancreatic insufficiency 55 fluticasone salmeterol 55 Octreotide 55 locoregional recurrence 55 intranasal formulation 55 amphotericin B. 55 clinically evaluable patients 55 terlipressin 55 BCR ABL inhibitor 55 cell lymphoma CTCL 55 lipid elevations 55 hepatocellular cancer 55 Cethromycin 55 noninferior 55 abdominal irradiation 55 pediatric Crohn disease 55 protease inhibitors PIs 55 cytotoxic therapies 55 neuroblastoma tumors 55 selective agonist 55 isoenzyme 55 Mimpara 55 delafloxacin 55 nonnucleoside reverse transcriptase inhibitors 55 immunotoxins 55 colorectal cancer CRC 55 sorafenib tablets 55 microbiological eradication 55 Loxapine 55 oxaliplatin Eloxatin 55 Certolizumab pegol 55 hereditary antithrombin deficiency 55 Hepatitis B Virus 55 HER2 expression 55 Romiplostim 55 Lyophilized 55 Omalizumab 55 urothelial bladder cancer 55 ASCUS 55 ANDA Filing 55 Haemophilus b Conjugate 55 lamivudine resistant 55 posaconazole 55 HbA 1c levels 55 Camptothecin 55 Bacillus Calmette Guerin BCG 55 Symmetrel 55 AGGRASTAT R Injection tirofiban 55 chlorambucil 55 osteoarthritis rheumatoid arthritis 55 histone deacetylase inhibitor 55 azacytidine 55 steroid dexamethasone 55 Methicillin 55 diagnose coronary artery 55 tyrosine kinase inhibitor TKI 55 cycloserine 55 salmeterol fluticasone propionate 55 sodium benzoate prescription 55 Microsphere 55 Vectical 55 comparator arm 55 AMN# [001] 55 precancerous cervical lesions 55 Vaccine Protects Against 55 chemotherapy induced thrombocytopenia 55 Presents Preclinical 55 Immunosuppressive 55 Tasigna nilotinib 55 severe oral mucositis 55 metastatic GIST 55 Torisel temsirolimus 54 C. trachomatis 54 HBeAg 54 pegIFN 54 Novel Small Molecule 54 AVAPRO 54 Actimmune ® 54 chronic ITP patients 54 autologous SCT 54 TT genotype 54 Phase 2a Trial 54 toenail onychomycosis 54 oxacillin 54 NRTI backbone 54 NanoEmulsion 54 macrocyclic lactone 54 S.aureus 54 Aptivus ® 54 Protease inhibitors 54 severe hypercholesterolemia 54 Submits Response 54 Adjuvanted 54 null mice 54 RAPTIVA 54 Saforis 54 1mg tablets 54 chronic immune thrombocytopenic 54 E1 INT TM 54 SGPT 54 Pegasys peginterferon alfa 2a 54 syndrome IBS 54 Chlamydia pneumoniae 54 follicular lymphomas 54 aminoglycoside antibiotics 54 Estradiol 54 Presents Positive 54 Myoblast 54 chlorthalidone 54 cefotaxime 54 gastrointestinal stromal tumors GISTs 54 sulfadiazine 54 ABCB1 54 chronic bronchitis AECB 54 idiopathic thrombocytopenic purpura ITP 54 R bendamustine hydrochloride 54 Soliris eculizumab 54 pegylated interferon alfa 54 genotype 1a 54 Lactobacillus KW 54 bacillus Calmette Guerin 54 thrombocytopenic 54 generation purine nucleoside 54 amikacin 54 Epstein Barr Virus EBV 54 Enterobacter cloacae 54 vivax 54 anaplastic astrocytomas 54 Initiates Clinical 54 TELINTRA 54 IBS C 54 Begins Dosing 54 Aviptadil 54 Motexafin Gadolinium 54 Divalproex Sodium 54 mecasermin 54 efavirenz EFV 54 sunitinib Sutent 54 fumarate 54 capreomycin 54 l lysine 54 deletion 5q 54 Virologic 54 PEG IFN 54 Cetuximab Erbitux 54 primary dysmenorrhea 54 bacteremic 54 Adjunctive Therapy 54 Drug Resistant 54 rheumatoid arthritis Crohn disease 54 anti inflammatory NSAID 54 ciprofloxacin hydrochloride 54 gabapentin Neurontin 54 formerly LymphoStat B 54 photosensitizing agent 54 maleate 54 KRAS status 54 thyroid carcinoma 54 bioavailable testosterone 54 neutropaenia 54 Recombinant interferon alpha 54 Somatostatin 54 Cutaneous 54 sublingual tablets 54 bFGF 54 gemcitabine cisplatin 54 hypertensives 54 Nipent R 54 Herpes Zoster 54 hematopoietic cancers 54 R5 tropic 54 Amgen Neulasta R 54 constipation OIC 54 MenACWY 54 VALSTAR 54 amphotericin 54 BoNT 54 Leydig cell 54 lupus anticoagulant 54 Neulasta pegfilgrastim 54 expressors 54 Clevudine 54 atypical antipsychotic medication 54 p# biomarker 54 intradermal injection 54 β lactam 54 Trichophyton rubrum 54 Initiates Phase II 54 interferon alfa 2b 54 elevated triglyceride levels 54 oropharyngeal candidiasis 54 TYGACIL 54 fentanyl buccal tablet 54 Intra arterial 54 ALN HPN 54 Raptiva R 54 biochemical relapse 54 situ CIS 54 reslizumab 54 Saizen ® 54 metastatic lymph nodes 54 tenofovir DF 54 Mylan Receives Approval 54 antibody MAb 54 coagulase negative 54 latent celiac disease 54 tipranavir ritonavir 54 CIN3 + 54 Cystatin C 54 esophageal gastric 54 serum urate levels 54 lexidronam injection 54 castrate resistant prostate cancer 54 arthritis PsA 54 Eloxatin oxaliplatin 54 Partial Response 54 M#V 54 HLA A2 54 lucinactant 54 hepatitis C HCV 54 sodium stibogluconate 54 Inactivation 54 arteritis 54 resected pancreatic cancer 54 inhibit replication 54 rheumatoid arthritis osteoarthritis ankylosing 54 inhalation powder 54 chronic periodontitis 54 reflux disease GERD 54 anti infective treatments 54 Amino acid 54 injected subcutaneously 54 therapeutically inactive prodrug 54 Simulect 54 candidates Azedra TM 54 ACTIQ ® 54 shingles herpes zoster 54 Ventavis ® 54 heterozygotes 54 sitosterol 54 hA# 54 ketolide antibiotic 54 resistant mutants 54 Sprycel dasatinib 54 lymphoma subtypes 54 Cefixime 54 congenital ichthyosis 54 VISICOL R 54 hepatoma 54 Gliadel R 54 PD# [005] 54 Gamunex C 54 Civacir 54 Sanvar R 54 5 HT3 antagonist 54 Elevated liver enzymes 53 LymphoStat B belimumab 53 hereditary deficiency 53 Romidepsin 53 Congenital Emphysema 53 SNT MC# 53 HIV seropositive 53 RTP #i 53 Latent TB 53 paclitaxel Taxol R 53 S aureus 53 seropositive patients 53 detemir 53 CMV infection 53 infused intravenously 53 Sifrol ® 53 aspartate aminotransferase 53 recurrent herpes labialis 53 glulisine 53 baseline LDH 53 nanomolar 53 colon carcinoma 53 infusional 5-FU/LV 53 virologic failure 53 Mutational 53 uremic pruritus 53 Squamous Cell Carcinoma 53 patients undergoing percutaneous 53 AGHD 53 thymidine kinase 53 rotigotine transdermal patch 53 Serostim ® 53 BCG refractory carcinoma 53 prostate carcinomas 53 Stage IIB 53 Multaq dronedarone 53 pCR 53 Kaletra lopinavir ritonavir 53 Pazopanib 53 Flu Cy 53 Lubiprostone 53 immuno compromised patients 53 methylnaltrexone bromide 53 Zavesca ® 53 grade gliomas 53 Paraplatin ® carboplatin 53 polysaccharide vaccine 53 aminoglycosides 53 Epithelial Cell 53 alpha interferon 53 alfa 2a 53 CCR5 tropic 53 CIMZIA TM certolizumab pegol 53 thrombogenic 53 histone deacetylase inhibitors 53 adeno associated viruses 53 Initiates Phase 2b 53 Familial Adenomatous Polyposis FAP 53 Launches Generic Version 53 Oncaspar 53 Immunoglobulin 53 Pathway Inhibitor 53 Haptoglobin 53 fosamprenavir 53 ACOMPLIA R 53 Clostridium difficile associated 53 adefovir dipivoxil 53 patientswith 53 methicillin susceptible Staphylococcus aureus 53 Adhibit 53 Panzem R 53 miconazole Lauriad R 53 Protease 53 evaluating picoplatin 53 lactate dehydrogenase 53 Hazard Ratio 53 dose atorvastatin 53 PBMCs